Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
relief Targeted amino acids to support muscle and tissue repair and physical recovery
Published preclinical work associates it with collagen and decorin regulation and with broad gene-expression shifts across ECM-related markers
Phase 1: Weeks 13 (Disc Repair Priority) BPC-157: 500mcg/day subQ TB-500: 2.5mg/week subQ GHK-Cu: 1mg/day subQ Focus: disc tissue repair, nerve decompression, anti-inflammation Activity: physical therapy, gentle mobility, no loading Phase 2: Weeks 48 (Add Recomp Layer) Continue Phase 1 stack Add CJC-1295 no DAC + Ipamorelin: 100mcg each, pre-bed This layer drives GH pulsatility for tissue remodeling and begins the body recomposition phase Activity: begin light lifting as cleared by PT Phase 3: Weeks 9+ (Maintenance and Fat Loss) TB-500: Drop to maintenance 1.25mg/week BPC-157: Can drop to 250mcg/day or 5 days/week CJC+Ipa: Continue pre-bed Optional add: Tesamorelin (12mg/day, 5 days/week) for visceral fat and GH optimization pairs well with CJC+Ipa Optional add: Retatrutide for more aggressive fat loss if that's a priority What to Expect: Recovery Timeline Weeks 12: Reduced acute nerve pain is often the first noticeable change
While BPC-157 targets localized repair in muscles, tendons, and the gastrointestinal tract, TB-500 works systemically to promote cell migration, improve flexibility, and support new blood vessel formation throughout the body
The treatment process begins with an initial consultation where we assess your health history and determine if peptide therapy aligns with your wellness goals
US$ 21.12
US$ 21.95
US$ 23.94
US$ 29.33
